AAAAAA
Results: 26-29/29
Authors:
Garderet, L
Snell, V
Przepiorka, D
Schenk, T
Lu, JG
Marini, F
Gluckman, E
Andreeff, M
Champlin, RE
Citation: L. Garderet et al., Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations, TRANSPLANT, 67(1), 1999, pp. 124-130
Authors:
Przepiorka, D
Smith, TL
Folloder, J
Khouri, I
Ueno, NT
Mehra, R
Korbling, M
Huh, YO
Giralt, S
Gajewski, J
Donato, M
Cleary, K
Claxton, D
Braunschweig, I
van Besien, K
Andersson, BS
Anderlini, P
Champlin, R
Citation: D. Przepiorka et al., Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation, BLOOD, 94(4), 1999, pp. 1465-1470
Authors:
Guardiola, P
Anderson, JE
Bandini, G
Cervantes, F
Runde, V
Arcese, W
Bacigalupo, A
Przepiorka, D
O'Donnell, MR
Polchi, P
Buzyn, A
Sutton, L
Cazals-Hatem, D
Sale, G
de Witte, T
Deeg, HJ
Gluckman, E
Citation: P. Guardiola et al., Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: A European group for blood and marrow transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center collaborative study, BLOOD, 93(9), 1999, pp. 2831-2838
Authors:
Khouri, IF
Romaguera, J
Kantarjian, H
Palmer, JL
Pugh, WC
Korbling, M
Hagemeister, F
Samuels, B
Rodriguez, A
Giralt, S
Younes, A
Przepiorka, D
Claxton, D
Cabanillas, F
Champlin, R
Citation: If. Khouri et al., Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma, J CL ONCOL, 16(12), 1998, pp. 3803-3809